Perrine Pennamen

1.2k total citations · 1 hit paper
15 papers, 637 citations indexed

About

Perrine Pennamen is a scholar working on Molecular Biology, Cell Biology and Genetics. According to data from OpenAlex, Perrine Pennamen has authored 15 papers receiving a total of 637 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Cell Biology and 4 papers in Genetics. Recurrent topics in Perrine Pennamen's work include melanin and skin pigmentation (6 papers), RNA regulation and disease (4 papers) and Genomic variations and chromosomal abnormalities (3 papers). Perrine Pennamen is often cited by papers focused on melanin and skin pigmentation (6 papers), RNA regulation and disease (4 papers) and Genomic variations and chromosomal abnormalities (3 papers). Perrine Pennamen collaborates with scholars based in France, Germany and United Kingdom. Perrine Pennamen's co-authors include Caroline Rooryck, Aurélie Bedel, Jérôme Toutain, Julian Boutin, Sandrine Dabernat, Grégoire Cullot, Veronique Guyonnet‐Dupérat, Jean‐Marc Blouin, François Moreau‐Gaudry and Benoı̂t Arveiler and has published in prestigious journals such as Nature Communications, British Journal of Ophthalmology and Genetics in Medicine.

In The Last Decade

Perrine Pennamen

15 papers receiving 629 citations

Hit Papers

CRISPR-Cas9 genome editin... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Perrine Pennamen France 9 503 203 138 97 42 15 637
Jichao Deng China 15 568 1.1× 53 0.3× 295 2.1× 16 0.2× 29 0.7× 22 669
Chunwei Zheng China 12 580 1.2× 26 0.1× 273 2.0× 8 0.1× 57 1.4× 21 733
Thijs van Vlijmen Netherlands 6 423 0.8× 444 2.2× 53 0.4× 24 0.2× 29 0.7× 7 698
D. Dewran Koçak United States 8 1.5k 3.0× 23 0.1× 298 2.2× 39 0.4× 120 2.9× 9 1.6k
Musharraf Jelani Pakistan 17 401 0.8× 228 1.1× 142 1.0× 15 0.2× 14 0.3× 53 643
Dace Pjanova Latvia 11 169 0.3× 72 0.4× 76 0.6× 11 0.1× 25 0.6× 31 389
Zhiquan Liu China 17 647 1.3× 21 0.1× 279 2.0× 4 0.0× 47 1.1× 37 701
Mehdi Banan Iran 13 478 1.0× 30 0.1× 199 1.4× 6 0.1× 37 0.9× 29 628
Gou Takahashi Japan 8 315 0.6× 17 0.1× 151 1.1× 7 0.1× 14 0.3× 18 360
Stacy A. Francis United States 8 371 0.7× 85 0.4× 27 0.2× 40 0.4× 9 0.2× 8 619

Countries citing papers authored by Perrine Pennamen

Since Specialization
Citations

This map shows the geographic impact of Perrine Pennamen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perrine Pennamen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perrine Pennamen more than expected).

Fields of papers citing papers by Perrine Pennamen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Perrine Pennamen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perrine Pennamen. The network helps show where Perrine Pennamen may publish in the future.

Co-authorship network of co-authors of Perrine Pennamen

This figure shows the co-authorship network connecting the top 25 collaborators of Perrine Pennamen. A scholar is included among the top collaborators of Perrine Pennamen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Perrine Pennamen. Perrine Pennamen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Cullot, Grégoire, Julian Boutin, David Cappellen, et al.. (2023). Cell cycle arrest and p53 prevent ON-target megabase-scale rearrangements induced by CRISPR-Cas9. Nature Communications. 14(1). 4072–4072. 16 indexed citations
2.
Goizet, Cyril, William Camu, Christel Depienne, et al.. (2021). Evidence of mosaicism in SPAST variant carriers in four French families. European Journal of Human Genetics. 29(7). 1158–1163. 2 indexed citations
3.
Boutin, Julian, David Cappellen, Jérôme Toutain, et al.. (2021). CRISPR-Cas9 globin editing can induce megabase-scale copy-neutral losses of heterozygosity in hematopoietic cells. Nature Communications. 12(1). 4922–4922. 50 indexed citations
4.
Pennamen, Perrine, Linh Le, Angèle Tingaud‐Sequeira, et al.. (2020). BLOC1S5 pathogenic variants cause a new type of Hermansky–Pudlak syndrome. Genetics in Medicine. 22(10). 1613–1622. 55 indexed citations
5.
Pennamen, Perrine, Angèle Tingaud‐Sequeira, Vincent Michaud, et al.. (2020). Novel variants in the BLOC1S3 gene in patients presenting a mild form of Hermansky–Pudlak syndrome. Pigment Cell & Melanoma Research. 34(1). 132–135. 7 indexed citations
6.
Pennamen, Perrine, Angèle Tingaud‐Sequeira, Iveta Gažová, et al.. (2020). Dopachrome tautomerase variants in patients with oculocutaneous albinism. Genetics in Medicine. 23(3). 479–487. 36 indexed citations
7.
Michaud, Vincent, Sabine Defoort‐Dhellemmes, Isabelle Drumare, et al.. (2019). Clinical and molecular findings of FRMD7 related congenital nystagmus as adifferential diagnosis of ocular albinism. Ophthalmic Genetics. 40(2). 161–164. 1 indexed citations
8.
Cullot, Grégoire, Julian Boutin, Jérôme Toutain, et al.. (2019). CRISPR-Cas9 genome editing induces megabase-scale chromosomal truncations. Nature Communications. 10(1). 1136–1136. 310 indexed citations breakdown →
9.
Morice‐Picard, Fanny, Perrine Pennamen, Benoı̂t Arveiler, et al.. (2019). PADDAS syndrome associated with hair dysplasia caused by a de novo missense variant of PUM1. American Journal of Medical Genetics Part A. 179(6). 1030–1033. 5 indexed citations
10.
Lasseaux, Eulalie, Christian Hamel, Sabine Defoort‐Dhellemmes, et al.. (2018). Mild form of oculocutaneous albinism type 1: phenotypic analysis of compound heterozygous patients with the R402Q variant of the TYR gene. British Journal of Ophthalmology. 103(9). 1239–1247. 26 indexed citations
11.
Lasseaux, Eulalie, Claudio Plaisant, Vincent Michaud, et al.. (2018). Molecular characterization of a series of 990 index patients with albinism. Pigment Cell & Melanoma Research. 31(4). 466–474. 98 indexed citations
12.
Trimouille, Aurélien, Émilie Obre, Guillaume Banneau, et al.. (2018). An in-frame deletion in BICD2 associated with a non-progressive form of SMALED. Clinical Neurology and Neurosurgery. 166. 1–3. 7 indexed citations
13.
Trimouille, Aurélien, Angèle Tingaud‐Sequeira, Perrine Pennamen, et al.. (2018). Deletion in 2q35 excluding the IHH gene leads to fetal severe limb anomalies and suggests a disruption of chromatin architecture. European Journal of Human Genetics. 27(3). 384–388. 3 indexed citations
14.
Brun, S., Perrine Pennamen, Aurélien Mattuizzi, et al.. (2018). Interest of chromosomal microarray analysis in the prenatal diagnosis of fetal intrauterine growth restriction. Prenatal Diagnosis. 38(13). 1111–1119. 9 indexed citations
15.
Nguyen, Huong Minh, Fréderic Morel, Perrine Pennamen, et al.. (2014). Balanced complex chromosome rearrangement in male infertility: case report and literature review. Andrologia. 47(2). 178–185. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026